sibutramina atrolex 10 mg cápsula - نتائج البحث

viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - augnlækningar - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.

أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

venlafaxine alvogen (venlafaxine portfarma) hart forðahylki 150 mg

alvogen ehf. - venlafaxinum hýdróklóríð - hart forðahylki - 150 mg

أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

venlafaxine alvogen (venlafaxine portfarma) hart forðahylki 75 mg

alvogen ehf. - venlafaxinum hýdróklóríð - hart forðahylki - 75 mg

الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

lucentis

novartis europharm limited - ranibizumab - wet macular degeneration; macular edema; diabetes complications; myopia, degenerative; choroidal neovascularization - augnlækningar - lucentis er fram í fyrir fullorðna:meðferð neovascular (blautur) aldri-tengjast ský á auga (rÍsa)meðferð sjón skert vegna æðu neovascularisation (cnv)meðferð sjón skert vegna sykursýki ský bjúg (dme)meðferð sjón skert vegna ský bjúg efri að sjónhimnu æð stíflu (útibú rvo eða central rvo).